Conley J, Genenger B, Ashford B, Ranson M
Int J Mol Sci. 2024; 25(15).
PMID: 39126067
PMC: 11313315.
DOI: 10.3390/ijms25158493.
Hua X, Xiang D, Guo M, Qian X, Chen R, Li T
Cell Death Dis. 2022; 13(8):753.
PMID: 36045117
PMC: 9433410.
DOI: 10.1038/s41419-022-05205-w.
Lee J, Kim G, Lee J, Ryu J, Oh E, Kim H
Int J Mol Sci. 2022; 23(11).
PMID: 35682793
PMC: 9181131.
DOI: 10.3390/ijms23116117.
Hedberg M, Berry C, Moshiri A, Xiang Y, Yeh C, Attilasoy C
Int J Mol Sci. 2022; 23(7).
PMID: 35408839
PMC: 8998533.
DOI: 10.3390/ijms23073478.
Kelemen A, Carmi I, Seress I, Lorincz P, Tolgyes T, Dede K
Int J Mol Sci. 2022; 23(4).
PMID: 35216292
PMC: 8879498.
DOI: 10.3390/ijms23042180.
Is miRNA Regulation the Key to Controlling Non-Melanoma Skin Cancer Evolution?.
Tamas T, Baciut M, Nutu A, Bran S, Armencea G, Stoia S
Genes (Basel). 2021; 12(12).
PMID: 34946878
PMC: 8701953.
DOI: 10.3390/genes12121929.
Oh, the Mutations You'll Acquire! A Systematic Overview of Cutaneous Squamous Cell Carcinoma.
Droll S, Bao X
Cell Physiol Biochem. 2021; 55(S2):89-119.
PMID: 34553848
PMC: 8579759.
DOI: 10.33594/000000433.
Decreased TMEM40 expression is associated with malignant behavior of cutaneous squamous cell carcinoma and inhibits tumor progression.
Yu L, Liu J, Zhang T, Zheng X, Luo D, Zhu W
Oncol Lett. 2021; 22(2):606.
PMID: 34188708
PMC: 8227547.
DOI: 10.3892/ol.2021.12867.
Circular RNA profiles and the potential involvement of down-expression of hsa_circ_0001360 in cutaneous squamous cell carcinogenesis.
Chen P, Li C, Huang H, Liang L, Zhang J, Li Q
FEBS Open Bio. 2021; 11(4):1209-1222.
PMID: 33569895
PMC: 8016141.
DOI: 10.1002/2211-5463.13114.
The Current State of Research Regarding the Role of Non-Coding RNAs in Cutaneous Squamous Cell Carcinoma.
Chen S, Luo L, Chen H, He C
Onco Targets Ther. 2020; 13:13151-13158.
PMID: 33380805
PMC: 7767711.
DOI: 10.2147/OTT.S271346.
Downregulation of miR-10a inhibits cutaneous squamous cell carcinoma cell proliferation, migration, and invasion by targeting Syndecan-1.
Xiong Z, Jiang B, Li G
Int J Clin Exp Pathol. 2020; 13(10):2502-2512.
PMID: 33165429
PMC: 7642702.
Importance of microRNAs in Skin Oncogenesis and Their Suitability as Agents and Targets for Topical Therapy.
Gerloff D, Sunderkotter C, Wohlrab J
Skin Pharmacol Physiol. 2020; 33(5):270-279.
PMID: 33080592
PMC: 7677990.
DOI: 10.1159/000509879.
Overexpressed GATA3 enhances the sensitivity of colorectal cancer cells to oxaliplatin through regulating MiR-29b.
Wang W, Wang M, Xu J, Long F, Zhan X
Cancer Cell Int. 2020; 20:339.
PMID: 32760217
PMC: 7379773.
DOI: 10.1186/s12935-020-01424-3.
miR-365 (microRNA): Potential Biomarker in Oral Squamous Cell Carcinoma Exosomes and Extracellular Vesicles.
Coon J, Kingsley K, Howard K
Int J Mol Sci. 2020; 21(15).
PMID: 32727045
PMC: 7432426.
DOI: 10.3390/ijms21155317.
miR-27a Downregulation Promotes Cutaneous Squamous Cell Carcinoma Progression via Targeting EGFR.
Wang Y, Deng X, Dai Y, Niu X, Zhou M
Front Oncol. 2020; 9:1565.
PMID: 32039029
PMC: 6985147.
DOI: 10.3389/fonc.2019.01565.
MicroRNA Dysregulation in Cutaneous Squamous Cell Carcinoma.
Garcia-Sancha N, Corchado-Cobos R, Perez-Losada J, Canueto J
Int J Mol Sci. 2019; 20(9).
PMID: 31052530
PMC: 6540078.
DOI: 10.3390/ijms20092181.
Exosomal transmission between macrophages and cancer cells: new insights to stroma-mediated drug resistance.
Gil Z
Oncotarget. 2019; 9(99):37282-37283.
PMID: 30647866
PMC: 6324675.
DOI: 10.18632/oncotarget.26463.
MicroRNA-365 targets multiple oncogenes to inhibit proliferation, invasion, and self-renewal of aggressive endometrial cancer cells.
Wang C, Su K, Zhang Y, Zhang W, Chu D, Zhao Q
Cancer Manag Res. 2018; 10:5171-5185.
PMID: 30464615
PMC: 6215916.
DOI: 10.2147/CMAR.S174889.
MicroRNA-365 Inhibits Cell Growth and Promotes Apoptosis in Melanoma by Targeting BCL2 and Cyclin D1 (CCND1).
Zhu Y, Wen X, Zhao P
Med Sci Monit. 2018; 24:3679-3692.
PMID: 29858490
PMC: 6011806.
DOI: 10.12659/MSM.909633.
MicroRNA-365 promotes lung carcinogenesis by downregulating the USP33/SLIT2/ROBO1 signalling pathway.
Wang Y, Zhang S, Bao H, Mu S, Zhang B, Ma H
Cancer Cell Int. 2018; 18:64.
PMID: 29743814
PMC: 5930950.
DOI: 10.1186/s12935-018-0563-6.